Intuitive Surgical, Inc.
Analysis
Intuitive is deliberately charging less per operation, cutting instrument prices and selling refurbished machines, to reach cost-sensitive benign surgery. The bet is that those discounts pull in enough patients before slowing US procedure growth catches up.How much extra surgery volume does Intuitive need to offset the price cut?
- Intuitive is cutting prices on its own instruments to buy volume.
Q3 put a number on it: a 3% to 5% cut in instrument revenue per operation, aimed at high-volume benign surgery where cost blocks adoption. It builds from next year, so growth must come from more operations, not more money per case.
- Revenue is still outgrowing the number of operations performed.
Q3 revenue rose 22% while procedures rose 15%, the gap coming from newer-robot and single-port mix plus Force Feedback, used in only about 8% of those cases. That premium offsets the discounts, and it has far to run.How quickly is Force Feedback adoption expected to grow from 8% of cases?
- US procedure growth has slowed in each of the last three quarters.
US da Vinci growth slipped to 10% in Q3 from 14% in Q1, as patients put off benign cases after ACA subsidies lapsed; guidance was narrowed, not raised. The US pays for the rest of the business, so the cuts land where patients are pausing.How much of the US slowdown is ACA, and which procedures are deferred?
- International benign procedure adoptionThe bull case is that adoption abroad is still early, and wider use in hernia and gallbladder surgery keeps international growth well ahead of the United States.
- Capital demand and installed baseDemand for the newest multiport system and for refurbished prior-generation machines is adding hospital capacity, and management expects the upgrade cycle to run for years.
- Clinical evidence for robotic surgeryLarge published analyses showing fewer conversions to open surgery give hospital administrators the evidence they need to justify building and expanding robotic programs.
- Slowing United States proceduresThe bear case is that United States procedure growth has slowed as patients defer elective benign care, and it is unclear how much of that volume comes back.
- Lower instrument revenue per caseInstrument price reductions and a mandated cut in China lower what Intuitive earns per procedure, so procedure growth has to carry more of the revenue burden.
- China tenders and local suppliersChinese policy favors domestic robot makers and centralized tenders, and Intuitive placed very few systems there while its newest platforms await clearance.
| Politician | Transaction | Amount | Traded | Filed |
|---|---|---|---|---|
Donald Trump Republican · Executive | Sale | ≥$100K | Aug 28 | Oct 8 |
Donald Trump Republican · Executive | Purchase | ≥$1K | Aug 24 | Oct 8 |
Donald Trump Republican · Executive | Sale | ≥$1K | Aug 10 | Oct 8 |
Donald Trump Republican · Executive | Sale | ≥$15K | Jul 27 | Sep 22 |
Donald Trump Republican · Executive | Sale | ≥$1K | Jul 24 | Sep 22 |
Congressional trading data provided by QuiverQuant
How Intuitive Surgical turned $10.1B of revenue into $2.9B of operating income.
| Revenue | ||
|---|---|---|
| Instruments and Accessories | $6.0B | ▲ 18.51% YoY |
| Systems | $2.5B | ▲ 25.82% YoY |
| Services | $1.6B | ▲ 20.27% YoY |
| Total revenue | $10.1B | |
| Gross profit | $6.6B | 66.0% |
| Operating income | $2.9B | 29.3% |